Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

20050097.LumA

· B

16bce221-4357-5879-8d23-9ceb43d9e0cc

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
cancer_type_detailed
subtype
B
subtype
B

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • ESTROGEN_RESPONSE_EARLY+0.150
  • DNA_REPAIR+0.110
  • ESTROGEN_RESPONSE_LATE+0.100
  • BILE_ACID_METABOLISM-0.010
  • FATTY_ACID_METABOLISM-0.050
  • SPERMATOGENESIS-0.060
  • KRAS_SIGNALING_DN-0.070
  • PEROXISOME-0.090
  • APICAL_SURFACE-0.100
  • HEME_METABOLISM-0.110

Top 10 suppressed

  • EPITHELIAL_MESENCHYMAL_TRANSITION-0.650
  • MYC_TARGETS_V1-0.500
  • ANGIOGENESIS-0.480
  • PROTEIN_SECRETION-0.480
  • HEDGEHOG_SIGNALING-0.440
  • ANDROGEN_RESPONSE-0.390
  • MTORC1_SIGNALING-0.390
  • UV_RESPONSE_DN-0.390
  • UNFOLDED_PROTEIN_RESPONSE-0.370
  • CHOLESTEROL_HOMEOSTASIS-0.360

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

10 twins match this tumor's tissue · 0 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1R87
bladder-landscape@3
0.914
2SRR1313108
breast-umap@18
B0.909
3MNG1271
mng-umap@100
0.891
4a3380ca6-6c65-4543-9bdf-957b26c1daaf
colon-landscapes@1
0.888
5SRR35579841
breast-umap@18
B0.881
6ERR2278876
head-neck@1
0.873
7TCGA-E2-A2P6-01A-11R-A19W-07
breast-umap@18
B0.871
8SRR2016945
head-neck@1
0.870
9TCGA-EW-A423-01A-11R-A24H-07
breast-umap@18
B0.869
10SRR23303775
bladder-landscape@3
0.868

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 3 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
ESTROGEN_RESPONSE_EARLY0.150Inavolisib— uncovered
DNA_REPAIR0.110Idelalisib— uncovered
ESTROGEN_RESPONSE_LATE0.100Idelalisib— uncovered